FILING ANALYSIS · MONDAY, NOVEMBER 9
Tonix Pharmaceuticals Holding Corp. TNXP — 8-K: Results of Operations and Financial Condition
neutral
Tonix Pharmaceuticals reported a 37% increase in TONMYA net sales to $15 million and has approximately $163 million in cash and cash equivalents, but also announced that Dr. Reddy's Laboratories has filed an ANDA for a generic version of TONMYA, which could potentially impact future sales.
The filing
8-K - Tonix Pharmaceuticals Holding Corp. (0001430306) (Filer)
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →